Articles

WellPoint ‘too cheap to ignore’

Miscues by WellPoint Inc.’s executives have, over the past year, depressed the health insurer’s stock price nearly 20 percent. That’s the upshot of analyst opinions gathered by Barron’s magazine in a March 15 article.

Read More

Do electronic records really save money?

Even though researchers at the Indianapolis-based Regenstrief Institute Inc. demonstrated more than 20 years ago that electronic health records and test ordering systems significantly reduced costs in Indianapolis’ Wishard Health Services’ system, a recent study of electronic health records among office-based physicians came to the opposite conclusion.

Read More

Q&A

Jan Lundberg, Eli Lilly and Co.’s executive vice president of science and technology, discussed the Indianapolis-based drugmaker’s latest efforts to improve its research and development efforts.

Read More

FTC asks critics of Express Scripts-Medco deal for ideas

Two pharmacy groups opposing Express Scripts Inc.’s proposed acquisition of Medco Health Solutions Inc. said they were asked by the U.S. Federal Trade Commission to suggest ways to revise the $29.1 billion deal so it wouldn’t harm competition.

Read More

Lilly to try again to remove poison-pill provisions

Eli Lilly and Co.’s board is once again recommending the removal of a provision that makes the company an almost impossible target for hostile takeovers. The same proposal has fallen slightly short at each of the past two annual shareholder meetings.

Read More

Arcadia: Don’t buy our stock

Arcadia Resources Inc. is telling shareholders not to buy its stock because it is out of cash and faces a $40 million pile of debt that comes due on April 1.

Read More